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Abstract
Aim: The primary aim of this longitudinal study was to evaluate additional effects of 4-week
chlorhexidine digluconate (CHX) gel treatments to control Aggregatibacter actinomycetemcomitans
counts in children after professional dental prophylaxis. Porphyromonas gingivalis and Streptococcus
mutans counts were also determined to evaluate the secondary effects of anti-plaque treatments on
microbial shifts. Methods: Twenty-six children with A. actinomycetemcomitans counts >4 log10/
mL of saliva and/or Quigley-Hein plaque index >3.0 were enrolled in this study. Patients were
randomly assigned to groups GI (placebo gel), GII (0.5% CHX gel), GIII (1% CHX gel), and GIV
(2% CHX gel). Four sessions of treatment were performed during 4 weeks after a session of
professional dental prophylaxis. Real-Time polymerase chain reaction (PCR) was used to
determine viable microorganism counts in non-stimulated whole saliva samples collected at
baseline, one week, one month and three months after interruption of treatments. Results: A
reduction of all bacterial counts was detected after the 3-month follow-up in all groups. Lower
counts of P. gingivalis were achieved from 1 week on after treatments. The 2% CHX concentration
seemed to contribute to lower A. actinomycetemcomitans levels and increase S. mutans levels.
Conclusions: Professional dental prophylaxis was effective to control salivary levels of A.
actinomycetemcomitans, P. gingivalis and S. mutans. Additional antimicrobial effects, however,
were not observed by the combination of professional dental prophylaxis and 4-week chlorhexidine
gel treatments.
Keywords: aggressive periodontitis, professional prophylaxis, chlorhexidine, Aggregatibacter
actinomycetemcomitans, Porphyromonas gingivalis, Streptococcus mutans.
Introduction
Aggressive periodontitis (AgP) affects younger individuals and is
characterized by a rapid loss of the supporting connective tissue and alveolar
bone around teeth in the presence of oral biofilm1. The prevalence of AgP is
higher among Black individuals than among Caucasian individuals, ranging from
0.1% to 7.6%, with a tendency for familiar clustering of cases2.
Increased detection levels of Aggregatibacter actinomycetemcomitans in the
oral cavity is an indicator for the risk of development of AgP in children,
adolescents and young adults3–6. A. actinomycetemcomitans is a Gram-negative
facultative anaerobic microorganism acquired via maternal transmission7-8. It plays
an important role in the onset of localized AgP because of its virulence factors,
such as RTX leukotoxin and cytolethal distending toxin, which trigger
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Gel formulations
0%, 0.5%, 1% or 2% chlorhexidine concentrations
2% hydroxyethylcellulose
0.1% benzalkonium chloride 95 v/v
0.18% methylparaben
0.05% propylparaben
0.05% menthol crystal
7% ethyl alcohol 96 v/v 
0.5% polysorbate 20
15% sorbitol
100 mL of distilled water
Chemical properties
pH 5.8-6.5
viscosity ∼ 300.000 cPs
specific density 1.0546 g/mL
Table 1 – Formulations and chemical properties of different
gels.
immunological host responses activating osteoclastogenesis
and leading to tissue breakdown9.
Antimicrobial chemotherapeutic methods can be used
to prevent AgP. Chlorhexidine digluconate (CHX) is effective
against a large spectrum of Gram-positive and Gram-negative
oral microorganisms10. Short-term adjunctive use of CHX gel
and/or mouthrinses decreases periodontopathogen counts11-
12 and limits supra/subgingival biofilm re-growth after
mechanical removal of dental plaque13–16. Microbial re-
colonization of tooth surfaces, however, begins soon after
antimicrobial treatments17, which might induce shifts in the
composition of biofilms. Simultaneous identification of
certain bacteria may also change the clinical severity of
periodontal diseases. Ramsey and Whiteley18 (2009)
demonstrated an enhanced resistance and virulence of A.
actinomycetemcomitans in the presence of oral streptococci.
De Soete et al.19 (2005) observed higher Streptococcus mutans
counts in saliva of periodontal patients after scaling root
planning (SRP). Mayorga-Fayad et al.20 (2007) reported more
prevalent detection of Porphyromonas gingivalis in AgP patients.
To the best of our knowledge, salivary microbial shifts
after the association between mechanical removal of dental
plaque and CHX gel treatments have not yet been
investigated. The primary aim of this longitudinal study was
to evaluate additional effects of 4-week CHX gel treatments
to control A. actinomycetemcomitans counts in children after
professional dental prophylaxis. P. gingivalis and S. mutans
counts were also determined to evaluate the secondary effects
of anti-plaque treatments on microbial shifts.
Material and methods
Participants
The present study was conducted after approval by the
Ethics Committee of Bauru School of Dentistry, University
of São Paulo (Process #47/2006). Parents of patients attending
the Clinic of Pediatric Dentistry were invited to enroll their
children in the study. Parental agreement was documented
by signing a written informed consent.
In a preliminary screening, forty-eight 7-12-year-old
children donated saliva and were examined by a calibrated
dentist (intraobserver concordance 8>0.9) to determine Löe
and Silness21 (1963) gingival index (G-index) and Quigley
& Hein modified by Turesky dental plaque index22 (DP-
index). Patients with A. actinomycetemcomitans counts >4
log10/mL of saliva and/or DP-index >3.0 could be included
in the study. Consumption of antibiotics and non-steroidal
anti-inflammatory drugs up to 30 days before the study,
presence of supragingival calculus, severe malocclusion, oral
lesions in soft tissues and use of orthodontic appliances were
considered as exclusion criteria.
Twenty-six children were enrolled in the study and
randomly assigned to groups GI (control, placebo gel), GII
(0.5% chlorhexidine gel), GIII (1% chlorhexidine gel), and
GIV (2% chlorhexidine gel) by Microsoft Excel 2003®
software.
Clinical procedures
Non-stimulated whole saliva was collected into sterile
glass beaker for 5 min. Saliva samples were stored at -20oC
until DNA extraction of specific microorganisms23.
Professional dental prophylaxis with sodium bicarbonate jet
was performed before the first session of treatment. For that
purpose, dental plaque was previously disclosed by a
solution of 0.2% fuchsine to ensure the quality of procedures.
Then, CHX gels were dispensed into disposable trays and
applied on teeth for 1 min. Formulations and chemical
properties of CHX gels are depicted in Table 1. Excesses of
gel were removed and children were instructed to restrict
liquid and food intake for next 30 min. Treatments were
conducted once a week for 28 days. Clinical appointments
were scheduled 1 week, 1 month and 3 months after the
interruption of gel treatments to collect saliva samples and
determine gingival and dental plaque indexes.
Real Time PCR tests
Real time PCR tests were performed to allow the
detection and quantification of A. actinomycetemcomitans,
P. gingivalis , and S. mutans . After defrosting and
homogenizing the saliva samples, two aliquots of 500 µL
saliva each were diluted in 1 mL of sterile demineralized
water (1:2) and centrifuged (10,000 xg) at 4oC for 5 min.
Supernatants were discarded and pellets were washed three
times with sterile demineralized water (10000 xg, 4oC, 5 min)23.
One bacterial pellet was incubated with 100 µL of a solution
for cellular lyses (20 U/mL mutanolysin plus 0.2 mg/mL
lysozyme) at 37oC for 2 h. This mixture was boiled (100oC,
10 min) to extract bacterial DNA from S. mutans cells. Other
bacterial pellet was used to extract DNA from A.
actinomycetemcomitans and P. gingivalis cells. The pellet
was suspended in a mixture of 100 µL DNAse-free water and
100 µL InstaGene Matrix (Bio-Rad Laboratories Inc., Hercules,
CA, USA), and incubated at 56oC for 30 min. Then, the samples
were vortexed and boiled for 10 min. Unbroken cells and
large debris were removed by subsequent centrifugation
Oral antibacterial effect of chlorhexidine treatments and professional prophylaxis in children
Braz J Oral Sci. 12(2):132-137
134
Sequence (5’ – 3’)
A.actinomycetemcomitans
Forward CAGCATCTGCGATCCCTGTA
Reverse GCCCTTTGTCTTTCCTAGGT
P. gingivalis
Forward TACCCATCGTCGCCTTGGT
Reverse CGGACTAAAACCGCATACACTTG
S. mutans
Forward GCCTACAGCTCAGAGATGCTATTCT
Reverse GCCATACACCACTCATGAATTGA
Table 2 – Sequences of oligonucleotide primers.
Baseline 1 week 1 month 3 months
G-Index 1.12±0.31 1.05±0.37 0.97±0.32 1.09±0.24
GI DP-Index 3.07±0.50 3.30±0.50 3.51±0.43 2.75±0.95
G-Index 0.84±0.54 0.84±0.42 1.00±0.34 1.12±0.12
GII DP-Index 2.90±0.59 3.25±0.56 3.16±0.60 3.41±0.83
G-Index 1.15±0.30 1.04±0.25 1.07±0.36 1.02±0.19
GIII DP-Index 3.03±0.44 3.39±0.27 3.41±0.64 3.05±0.94
G-Index 0.88±0.53 1.06±0.30 1.25±0.29 1.05±0.46
GIV DP-Index 3.29±0.78 3.52±0.54 3.33±0.72 3.45±1.09
Table 3 – Mean (±SD) of gingival index (G-Index) and dental plaque
index (DP-Index) of groups GI (placebo gel), GII (0.5% CHX gel), GIII
(1% CHX gel), and GIV (2% CHX gel) after different follow-up times.
(10,000 xg, 3 min). Supernatants were used for Real-time
PCR DNA analysis.
Real-Time PCR DNA analysis was performed in an ABI
Prism 7000 system (Applied Biosystems, Warrington, UK),
1X Universal PCR Master-Mix (ABI), 200 nM of specific
primers, 1µL of the supernatant, and 250 nM of each quencher
dye (6-carboxyfluorescein and 6-carboxytetramethylrho-
damine). The specificities of the primers were initially
confirmed by BLAST with the National Center for
Biotechnology Information server (http://www.ncbi.nlm.nih.gov).
Oligonucleotide primer sequences are shown in Table 2.
Bacterial DNA levels were determined using the Ct method
and normalized by the volume of the supernatants.
Statistical analysis
Data were analyzed by NCSS/PASS® 2000 statistical
software (Kaysville, UT, USA). Microorganism counts were
log-transformed before statistical tests. Normality and
homogeneity of data were respectively evaluated by
Kolmogorov-Smirnov and Levene tests. Statistical differences
were assessed using parametric one-way ANOVA and Bonferroni
post-hoc test. Correlations between gingival or dental plaque
indexes and microorganism counts were observed by Pearson’s
test. The p values <0.05 were considered significant.
Results
Gingival and Dental Plaque Indexes
Fourteen male and 12 female children were enrolled in
the study (8.9±1.2 years). Correlations between gingival and
dental plaque indexes and A. actinomycetemcomitans (G-
Index r=-0.24, DP-Index r=-0.10), P. gingivalis (G-Index
r=-0.03, DP-Index r=-0.10), and S. mutans (G-Index r=
-0.14, DP-Index r=0.01) counts were not observed at baseline.
Both clinical indexes were statistically similar in different
treatment groups and times (Table 3).
Microorganism counts
P. gingivalis and S. mutans were identified in 61.5%
and 96.2% of children, respectively, at baseline. Bacterial
counts did not differ significantly between groups throughout
the study (p>0.05). The effectiveness of treatments was
demonstrated by statistical differences observed among
bacterial counts in different follow-up times. Considering
all groups (Table 4), the mean of A. actinomycetemcomitans
counts at 3 months (4.20±3.90) was significantly lower than
at baseline (5.98±1.96) (p<0.05). Similar differences were
verified in S. mutans counts between 3-month follow-up
(3.14±2.67) and baseline (4.29±2.31) (p<0.05). P.
gingivalis counts were statistically reduced from 1 week
(1.73±2.74) after interruption of treatments compared with
baseline (5.18±4.72) (p<0.05). Although P. gingivalis counts
gradually increased to 3.21±3.42 at 1-month and 3.37±3.12
at 3-month follow-ups, the levels still remained significantly
lower than at baseline (p<0.05).
The maintenance of lower P. gingivalis and S. mutans
counts were noticed in 100% and 84.6% children,
respectively, with initial P. gingivalis and S. mutans counts
>4 log10/mL of saliva. On the other hand, respectively 54.5%
and 69.2% children with initial P. gingivalis and S. mutans
counts <4 log10/mL of saliva showed higher microorganism
counts after 3 months of follow-up (Figures 1A, B and C).
A reduction in the percentage of children with salivary
A. actinomycetemcomitans counts >4 log10/mL of saliva
was observed in all groups since CHX treatments. The highest
CHX concentration (2%) seemed to contribute to obtain lower
levels of A. actinomycetemcomitans in most patients at the
end of the study (Figure 1A).
In comparison with baseline, the percentage of patients
with P. gingivalis counts >4 log10/mL of saliva decreased
after 1 week and 1 month of placebo and 0.5% CHX gel
treatments, whereas the percentage of patients did not vary
after 1% and 2% CHX gel treatments. After 3 months, different
Oral antibacterial effect of chlorhexidine treatments and professional prophylaxis in children
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CHX concentrations differed in controlling P. gingivalis
levels. Higher percentage of children with P. gingivalis counts
>4 log10 was noticed in the group GIII as compared to
groups GII and GIV (Figure 1B).
The results supported a trend of simultaneous increment
of CHX gel concentrations and S. mutans counts along time.
Treatments with 2% CHX gel increased S. mutans levels in
most patients 1 week and 3 months after CHX treatments
(Figure 1C).
Discussion
A positive impact on the prevention of AgP could be
achieved by a short-term reduction of salivary periodonto-
pathogens. This preliminary study demonstrated that one
session of professional dental prophylaxis can be effective
to reduce salivary counts of A. actinomycetemcomitans, P.
gingivalis and S. mutans in children. Additional antimicrobial
effects of CHX gels could not be demonstrated. After a 3-
month follow-up, most children showed lower salivary counts
of at least one microorganism, especially in patients with
specific bacterial counts >4 log10 at baseline.
The amounts of microbial deposits are inconsistent
with the severity of periodontal tissue destruction in AgP
patients23. High proportions of A. actinomycetemcomitans
and P. gingivalis can be associated with the onset of this
disease. The rapid identification and quantification of
periodontal microorganisms, therefore, permits early
treatments to prevent the colonization of tooth surfaces
for the maintenance of homeostasis of the periodontium.
Currently, i t  is possible to monitor oral microbial
compositions using diagnostic tools as Real-Time PCR24-
25. Umeda et al.23 (1998) demonstrated that PCR is a
specific and highly sensitive method for detection of
periodontopathogens in whole saliva. Our study focused
on the potential application of CHX gels to reduce salivary
pathogens, which would be able to colonize tooth and
radicular surfaces, and increase the risk of developing
periodontal diseases.
In the present study, disposable trays were used to
deliver CHX gels in the oral cavity of children. Dental plaque
and gingival indexes of all groups did not differ significantly
after treatments. Francis et al.14 (1987) demonstrated efficient
inhibition of dental plaque and control of gingival bleeding
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Treatment   Patient              A. actinomycetemcomitans                  P. gingivalis                                         S. mutans
group
Baseline 1 week 1 m 3 m Baseline 1 week 1 m 3 m Baseline 1 week 1 m 3 m
1 8.94 10.44 7.36 5.23 10.12 8.97 3.79 4.49 9.45 8.07 7.30 7.15
2 8.81 9.27 5.29 9.86 8.07 2.28 ND 4.60 9.10 ND 6.11 10.03
3 5.13 2.06 2.29 ND 2.96 ND ND 4.45 3.29 2.56 3.21 ND
GI 4 8.47 6.72 9.25 10.57 9.30 ND 8.55 2.89 8.10 6.44 1.56 ND
5 4.88 3.78 3.19 2.43 ND ND ND ND 2.51 4.08 0.54 ND
6 3.02 3.47 ND ND ND ND ND ND 5.23 5.09 5.28 ND
7 3.34 2.87 ND ND ND ND ND ND 5.06 7.21 5.19 5.22
            Mean±SD 6.1±2.6 5.5±3.3 3.9±3.6 4.0±4.6 4.4±4.7 1.6±3.4 1.8±3.3 2.3±2.3 6.1±2.8 4.8±2.8 4.2±2.5 3.2±4.2
8 4.22 ND 3.23 2.44 6.91 ND ND ND 5.17 6.56 3.96 ND
9 6.47 6.54 8.00 5.51 8.14 2.51 5.87 5.37 5.02 5.62 4.05 ND
10 5.90 ND 7.85 5.98 9.60 2.30 3.21 5.47 5.50 ND 4.42 3.80
GII 11 5.55 5.84 6.81 2.87 7.25 ND 4.04 4.56 6.02 5.86 3.03 4.00
12 8.15 6.46 5.91 2.89 6.64 ND 2.95 3.82 1.53 7.78 6.28 4.71
13 4.58 6.74 ND ND 5.89 1.71 ND ND 1.91 ND 3.18 3.64
            Mean±SD 5.8±1.4 4.3±3.3 5.3±3.1 3.3±2.2 7.4±1.3 1.1±1.2 2.7±2.3 3.2±2.6 4.2±1.9 4.3±3.4 4.2±1.2 2.7±2.1
14 8.21 6.64 9.52 10.07 13.94 ND 10.11 11.11 5.42 ND 5.12 4.24
15 5.43 6.65 6.87 11.78 11.74 3.99 3.33 ND 4.27 4.45 4.39 ND
16 6.91 6.08 5.89 5.36 6.02 ND ND 4.09 ND 5.54 ND 3.53
GIII 17 6.45 3.76 ND ND 13.14 2.70 5.64 6.09 5.61 4.40 3.48 4.18
18 4.33 10.68 6.09 5.72 ND 7.30 4.86 5.83 3.07 2.36 6.76 5.79
19 6.33 9.01 5.50 5.04 ND 6.30 ND 4.98 2.58 ND 2.72 3.84
20 5.35 4.30 8.82 8.87 ND ND 7.76 7.03 2.87 ND 2.12 ND
            Mean±SD 6.1±1.3 6.7±2.4 6.1±3.1 6.7±3.9 6.4±6.5 2.9±3.1 4.5±3.8 5.6±3.3 3.4±1.9 2.4±2.4 3.5±2.4 3.1±2.2
21 4.39 2.39 2.77 ND ND ND 3.00 ND 2.18 4.00 3.76 ND
22 6.58 5.20 5.50 2.59 ND ND 2.73 4.52 2.61 6.09 3.18 4.66
23 6.77 9.28 8.94 ND 8.42 7.00 7.94 ND 3.50 4.65 2.94 5.13
GIV 24 3.21 3.95 6.93 ND ND ND ND ND 2.33 2.83 4.96 3.40
25 8.31 4.94 2.93 2.59 6.44 ND ND ND 6.16 2.44 0.78 4.15
26 5.87 6.78 9.27 9.40 ND ND 9.75 8.31 3.06 ND 3.11 4.10
            Mean±SD 5.9±1.8 5.4±2.4 6.1±2.8 2.4±3.6 2.5±3.9 1.2±2.9 3.9±4.1 2.1±3.5 3.3±1.5 3.3±2.1 3.1±1.4 3.6±1.8
Table 4 – Mean (±SD) of salivary counts of A. actinomycetemcomitans, P. gingivalis, and S. mutans (log10) at baseline,
1 week and 3 months after treatments with placebo gel (GI), 0.5% CHX gel (GII), 1% CHX gel (GIII), and 2% CHX gel (GIV).
ND means microorganism not detected.
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Fig. 1 – Percentage of children with A. actinomycetemcomitans (A), P. gingivalis
(B) and S. mutans (C) counts >4 log10/mL of saliva in different groups and follow-
up times.
in patients treated with 4-week tray application of 1% CHX
gel. Slot et al.16 (2010) reported an improvement of dental
plaque control after tray application of 1% CHX gel
compared to 0.12% CHX dentifrice gel. Our contrasting
results could be explained by the inclusion of healthy
periodontal patients with low scores of dental plaque and
gingival indexes at baseline. According to Berchier et al.26
(2010), the increase of CHX concentration seems to enhance
the dental plaque control, although this could not be
considered clinically relevant.
Since the diversity of microorganisms from saliva and
dental plaque has been estimated in about 19,000 species-
level phylotypes27, multiple microbial clusters are possible
among individuals. In our study, the host-specific microbial
load can be illustrated by the detection of P. gingivalis and
S. mutans in respectively 61.5% and 73% children at
baseline. Similar treatments resulted in diverse antimicrobial
responses in different patients: 4-week 1% CHX gel treatment
was effective to reduce all bacterial counts in patient #17,
whereas the same regimen increased all microorganism counts
in patient #18. Lower S. mutans and P. gingivalis counts
and higher A. actinomycetemcomitans were detected in
patients #14 and #15. Filoche et al.28 (2008) showed a host
specificity of antimicrobial agents against ex vivo
microorganisms.
After a 3-month follow-up, professional dental
prophylaxis was effective to reduce at least one specific
bacterial count in all patients of group GI. Periodic dental
visits may also have contributed to the enhancement of dental
plaque control in children. The application of 0.5% CHX
gel decreased simultaneously A. actinomycetemcomitans, P.
gingivalis and S. mutans counts in most patients. Higher
counts of bacteria were detected in four out of seven patients
treated with 1% CHX gel. Two percent CHX gel treatments
were responsible for lowering A. actinomycetemcomitans
counts in 83.3% patients and raising S. mutans counts in
66.7% patients at the end of the study. Although speculative,
our findings could indicate a possible trend of microbial
shifts between periodontopathogens and cariogenic
microorganisms with increasing concentration of CHX gels.
De Soete et al.19 (2005) reported a significant increase of
detection of S. mutans after SRP. Clinical interventions could
induce local shifts in composition of biofilms from
predominant anaerobic and proteolytic microorganisms to
aerobic and acidogenic microorganisms. Other microbial
relationships can be expressed by association among specific
substrate, microbiological composition and metabolism. For
example, lactate - a metabolite of cariogenic bacteria - can
be used as a carbon source for Veilonella sp. These bacteria
are able to produce considerable amount of menaquidone,
an organic source of vitamin K, essential to growth of P.
gingivalis and T. denticola29.
Thresholds of minimal P. gingivalis and S. mutans counts
were not established in our inclusion criteria. Independently
of treatment group, most patients with initial S. mutans and
P. gingivalis counts >4 log10/mL of saliva presented a trend
to reduction of bacterial counts after 3-month follow-up,
whereas respectively 69.2% and 54.5% patients with S.
mutans and P. gingivalis counts <4 log10/mL of saliva
presented a trend to increase bacterial counts along time.
Moreover, faster reductions of P. gingivalis counts seemed
to indicate more sensitivity to mechanical and chemothera-
peutic treatments than A. actinomycetemcomitans and S.
mutans . These findings suggest shifts in microbial
compositions after treatments for dental plaque control.
Sekino et al.12 (2004) demonstrated that the combination of
a 0.2% CHX mouthrinse and a 1% CHX gel decreased salivary
microorganisms and blocked tooth recolonization by A.
actinomycetemcomitans and P. gingivalis. A significant
reduction of periodontopathogen counts after SRP and full-
mouth disinfection with CHX was also described by Quirynen
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et al.17 (1999). Perinetti et al.11 (2004) achieved a reduction
of A. actinomycetemcomitans and S. mutans counts in
periodontal pockets after irrigation with 1% CHX gel.
Some issues should be discussed regarding the results.
It is possible that significant differences were not observed
among the different groups of this study due to some
limitations: (1) small sample size, (2) allocation of participants
into four distinct groups, and (3) diversity of antimicrobial
responses from each patient. Also, inclusion criteria limited
the enrollment of participants in this study, especially A.
actinomycetemcomitans counts >4 log10/mL of saliva.
Additionally, the follow-up could be extended to 6 months
to adequately assess the effect of chlorhexidine substantivity
on clinical and microbiological parameters.
In conclusion, this study demonstrated that mechanical
dental plaque control can be used as an effective preventive
strategy to control salivary counts of A. actinomycetemco-
mitans, P. gingivalis and S. mutans, contributing to the
maintenance of periodontal health. Further randomized
clinical trials are needed to establish safe protocols for
demonstrating additional benefits of chlorhexidine treatments
against pathogenic microorganisms in saliva, with minimum
modifications of oral homeostasis.
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